Tandus, Mark Joseph V.

HRN: 28-68-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFUROXIME 1.5GM (VIAL)
03/08/2026
03/15/2026
IVT
750mg
Q8
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: